Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2025-12-26 @ 2:36 PM
Study NCT ID:
NCT03875859
Status:
TERMINATED
Last Update Posted:
2021-05-20
First Post:
2019-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
Sponsor:
Kavita Sarin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-13
First Submit QC Date:
None
Study First Post Date:
2019-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-04-28
Results First Submit QC Date:
None
Results First Post Date:
2021-05-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-28
Last Update Post Date:
2021-05-20
Last Update Post Date Type:
ACTUAL